Stay updated on Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial

Sign up to get notified when there's something new on the Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T15:30:51.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now identifies the site revision as v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-11T14:53:20.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the usual study details and navigation for NCT03851588. This indicates an access restriction to the record rather than a content update on the study page.
    Difference
    20%
    Check dated 2026-09-20T08:36:14.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6 on the page, indicating a software version update without changes to trial information.
    Difference
    0.1%
    Check dated 2026-08-29T23:46:45.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page’s version label was updated from Revision: v3.6.4 to Revision: v3.6.5. This is a minor release tag update rather than a modification to the study content or layout.
    Difference
    0.1%
    Check dated 2026-08-08T22:23:06.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The page now displays a newer site revision, updating from v3.6.3 to v3.6.4, indicating a software deployment. The update is limited to system metadata and does not modify study content or user-facing features.
    Difference
    0.1%
    Check dated 2026-07-25T12:57:21.000Z thumbnail image

Stay in the know with updates to Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial page.